4-aminobutyric acid

4-aminobutyric acid is a lipid of Fatty Acyls (FA) class. 4-aminobutyric acid is associated with abnormalities such as Epilepsy and Premenstrual syndrome. The involved functions are known as Binding (Molecular Function), neuron survival, Process, Uptake and physiological aspects. 4-aminobutyric acid often locates in Microglial, Neurofilament, Neuraxis, Brain region and Neurites. The associated genes with 4-aminobutyric acid are arginine methyl ester, SLC33A1 gene, NKS1 gene, P4HTM gene and ITSN2 gene. The related lipids are pregnenolone sulfate, pregnane-20-one, Pregnanes, Steroids and endogenous steroids.

Cross Reference

Introduction

To understand associated biological information of 4-aminobutyric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 4-aminobutyric acid?

4-aminobutyric acid is suspected in Premenstrual syndrome, Epilepsy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 4-aminobutyric acid

MeSH term MeSH ID Detail
Fetal Alcohol Spectrum Disorders D063647 6 associated lipids
Genetic Diseases, Inborn D030342 4 associated lipids
Vitamin B 6 Deficiency D026681 10 associated lipids
Hyperammonemia D022124 5 associated lipids
Embryo Loss D020964 5 associated lipids
Paraparesis D020335 1 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Serotonin Syndrome D020230 1 associated lipids
Epilepsy, Reflex D020195 5 associated lipids
Gangliosidoses, GM2 D020143 1 associated lipids
Cocaine-Related Disorders D019970 3 associated lipids
Hemifacial Spasm D019569 1 associated lipids
Neck Pain D019547 2 associated lipids
Gingival Overgrowth D019214 7 associated lipids
Neuroaxonal Dystrophies D019150 3 associated lipids
Congenital Disorders of Glycosylation D018981 1 associated lipids
Encephalitis, Viral D018792 3 associated lipids
Tension-Type Headache D018781 1 associated lipids
Hypokinesia D018476 2 associated lipids
Neuroendocrine Tumors D018358 4 associated lipids
Per page 10 20 50 100 | Total 280

PubChem Associated disorders and diseases

What pathways are associated with 4-aminobutyric acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 4-aminobutyric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 4-aminobutyric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 4-aminobutyric acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 4-aminobutyric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 4-aminobutyric acid?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 4-aminobutyric acid

Download all related citations
Per page 10 20 50 100 | Total 40318
Authors Title Published Journal PubMed Link
Miyamoto S et al. [Resolution of (3RS)-4-amino-3-hydroxybutanamide (author's transl)]. 1979 Yakugaku Zasshi pmid:536895
Miyamoto S et al. [Synthesis and resolution of (3RS)-4-amino-3-hydroxybutananilide (author's transl)]. 1979 Yakugaku Zasshi pmid:536896
Miyamoto S and Kurono M [Resolution of (3RS)-4-amino-3-hydroxybutanoic acid (author's transl)]. 1979 Yakugaku Zasshi pmid:536897
Ohtsuki S [Physiological function of blood-brain barrier transporters as the CNS supporting and protecting system]. 2004 Yakugaku Zasshi pmid:15516806
Shimada C et al. [Drug-induced seizures in taurine-deficient mice]. 1991 Yakubutsu Seishin Kodo pmid:1799096
Takeuchi H et al. [Pharmacology of molluscan giant neurons]. 1990 Yakubutsu Seishin Kodo pmid:1982775
Kaneko A [Neural circuit of the retina subserving processing of color and spatial signals as revealed by studies on dissociated solitary neurons]. 1988 Yakubutsu Seishin Kodo pmid:3250155
Kikumoto O et al. [Effects of risperidone on catalepsy and cerebral dopamine, serotonin and GABA metabolism in the rat: comparison with haloperidol]. 1993 Yakubutsu Seishin Kodo pmid:7686319
Nabeshima T et al. [Phencyclidine, a drug which induces psychosis: its neuropharmacological actions]. 1984 Yakubutsu Seishin Kodo pmid:6395556
Sekine Y et al. Metabolism in rats and man of piromidic acid, a new antibacterial agent. 1976 Xenobiotica pmid:1274382
Hoyle CH Non-adrenergic, non-cholinergic control of the urinary bladder. 1994 World J Urol pmid:7532513
Sieghart W [GABA(A) benzodiazepine receptors and epilepsy]. 1990 Wien. Klin. Wochenschr. pmid:2160756
Kneussl M et al. [A model of the central control of respiration]. 1986 Wien. Klin. Wochenschr. pmid:3765644
Jellinger K et al. [The significance of biogenic amines in cerebral infarction (author's transl)]. 1979 Wien. Klin. Wochenschr. pmid:452604
Schober W and Guss H [Treatment of forced weeping (author's transl)]. 1976 Wien. Klin. Wochenschr. pmid:1014709
Bornschein H et al. [Aspartate transfer across the blood-retina barrier (author's transl)]. 1977 Wien. Klin. Wochenschr. pmid:17948
Placheta P and Singer E [Experimental changes of GABA receptor binding in the central nervous system (author's transl)]. 1980 Wien. Klin. Wochenschr. pmid:6258330
Carlsson VA [The contribution of drug research to the understanding of schizophrenia]. 1975 Wien Med Wochenschr pmid:3029
Kanios K [Etiopathogenesis and treatment of Alzheimer's disease]. 1986 Wiad. Lek. pmid:3014757
Jarema M [Progress in the studies of the etiology and treatment of Alzheimer's disease]. 1988 Wiad. Lek. pmid:3070943